Literature DB >> 16789908

In silico discrimination of single nucleotide polymorphisms and pathological mutations in human gene promoter regions by means of local DNA sequence context and regularity.

Imtiaz A Khan1, Matthew Mort, Paul R Buckland, Michael C O'Donovan, David N Cooper, Nadia A Chuzhanova.   

Abstract

DNA sequence features were sought that could be used for the in silico ascertainment of the likely functional consequences of single nucleotide changes in human gene promoter regions. To identify relevant features of the local DNA sequence context, we transformed into consensus tables the nucleotide composition of sequences flanking 101 promoter SNPs of type C<-->T or A<-->G, defined empirically as being either 'functional' or 'non-functional' on the basis of a standardised reporter gene assay. The similarity of a given sequence to these consensus tables was then measured by means of the Shapiro-Senapathy score. A decision rule with the potential to discriminate between empirically ascertained functional and non-functional SNPs was proposed that potentiated discrimination between functional and non-functional SNPs with a sensitivity of 80% and a specificity of 20%. Two further datasets (viz. disease-associated SNPs of types A<-->G and C<-->T (N = 75) and pathological promoter mutations (transitions, N = 114)) were retrieved from the Human Gene Mutation Database (HGMD; http://www.hgmd.org/) and analyzed using consensus tables derived from the functional and non-functional promoter SNPs; approximately 70% were correctly recognized as being of probable functional significance. Complexity analysis was also used to quantify the regularity of the local DNA sequence environment. Functional SNPs/mutations of type C<-->T were found to occur in DNA regions characterized by lower average sequence complexity as measured with respect to symmetric elements; complexity values increased gradually from functional SNPs and pathological mutations to functional disease-associated SNPs and non-functional SNPs. This may reflect the internal axial symmetry that frequently characterizes transcription factor binding sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16789908

Source DB:  PubMed          Journal:  In Silico Biol        ISSN: 1386-6338


  6 in total

1.  Two novel polymorphisms of bovine SIRT2 gene are associated with higher body weight in Nanyang cattle.

Authors:  Xiaomei Sun; Mingxun Li; Dan Hao; Liushuai Hua; Xianyong Lan; Chuzhao Lei; Shenrong Hu; Xinglei Qi; Hong Chen
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  Recent computational approaches to understand gene regulation: mining gene regulation in silico.

Authors:  I Abnizova; T Subhankulova; Wr Gilks
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

3.  Prediction of functional regulatory SNPs in monogenic and complex disease.

Authors:  Yiqiang Zhao; Wyatt T Clark; Matthew Mort; David N Cooper; Predrag Radivojac; Sean D Mooney
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

4.  A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease.

Authors:  Damian Smedley; Max Schubach; Julius O B Jacobsen; Sebastian Köhler; Tomasz Zemojtel; Malte Spielmann; Marten Jäger; Harry Hochheiser; Nicole L Washington; Julie A McMurry; Melissa A Haendel; Christopher J Mungall; Suzanna E Lewis; Tudor Groza; Giorgio Valentini; Peter N Robinson
Journal:  Am J Hum Genet       Date:  2016-08-25       Impact factor: 11.025

5.  Extensive In Silico Analysis of ATL1 Gene : Discovered Five Mutations That May Cause Hereditary Spastic Paraplegia Type 3A.

Authors:  Mujahed I Mustafa; Naseem S Murshed; Abdelrahman H Abdelmoneim; Miyssa I Abdelmageed; Nafisa M Elfadol; Abdelrafie M Makhawi
Journal:  Scientifica (Cairo)       Date:  2020-04-19

6.  In Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid Leukemia.

Authors:  Mujahed I Mustafa; Zainab O Mohammed; Naseem S Murshed; Nafisa M Elfadol; Abdelrahman H Abdelmoneim; Mohamed A Hassan
Journal:  Cancer Inform       Date:  2019-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.